AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which would help the Anglo-Swedish drugmaker develop therapies for chronic ...

AstraZeneca has signed a deal worth up to $5.2bn to work with a Chinese biotech company using AI to develop new treatments for chronic diseases.

The latest trading day saw Astrazeneca (AZN) settling at $73.83, representing a +1.12% change from its previous close.

Astrazeneca (AZN) closed the most recent trading day at $71.93, moving -1.24% from the previous trading session.

A Google Translate screenshot correctly shows that the name of the pharmaceutical company AstraZeneca, when written as “A stra ze neca,” means “a road to death” in Latin.

AstraZeneca has opened its first U.S.-operated cell therapy manufacturing plant in Rockville, Maryland, as part of its ongoing $3.5 billion investment in American innovation.

Achilles Therapeutics transferred TRACERx data and samples to AstraZeneca, finalizing a strategic review and receiving $12M.

AstraZeneca expects a sales hit in China, one of its most important international markets. The drugmaker's issues in China have weighed heavily on its performance of late, and its stock is down by ...

AstraZeneca expects a sales hit in China, one of its most important international markets. The drugmaker's issues in China have weighed heavily on its performance of late, and its stock is down by ...

AstraZeneca and Daiichi Sankyo have shared the data they believe can secure approval for datopotamab deruxtecan (Dato-DXd) at the second attempt. The partners showed off subgroup overall survival ...

The company believes Chinese authorities are probing allegations that two current and two former employees had illegally imported cancer drugs.

AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune system to make certain cancer drug trials more efficient, the latter said ...